{"id":"https://openalex.org/W2157024344","doi":"https://doi.org/10.1128/aac.00699-06","title":"Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1","display_name":"Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1","publication_year":2006,"publication_date":"2006-09-27","ids":{"openalex":"https://openalex.org/W2157024344","doi":"https://doi.org/10.1128/aac.00699-06","mag":"2157024344","pmid":"https://pubmed.ncbi.nlm.nih.gov/17005807","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1610098"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00699-06","doi":"https://doi.org/10.1128/aac.00699-06","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00699-06","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1610098","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032705889","display_name":"Jose D. Murga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116119","display_name":"Progenics Pharmaceuticals (United States)","ror":"https://ror.org/023ka9926","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose D. Murga","raw_affiliation_strings":["Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591","institution_ids":["https://openalex.org/I4210116119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024405434","display_name":"Michael Franti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116119","display_name":"Progenics Pharmaceuticals (United States)","ror":"https://ror.org/023ka9926","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Franti","raw_affiliation_strings":["Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591","institution_ids":["https://openalex.org/I4210116119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041876321","display_name":"Daniel C. Pevear","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116119","display_name":"Progenics Pharmaceuticals (United States)","ror":"https://ror.org/023ka9926","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel C. Pevear","raw_affiliation_strings":["Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591","institution_ids":["https://openalex.org/I4210116119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035255731","display_name":"Paul Jay Maddon","orcid":"https://orcid.org/0000-0002-2264-6270","observed_orcids":["https://orcid.org/0000-0002-2264-6270"]},"institutions":[{"id":"https://openalex.org/I4210116119","display_name":"Progenics Pharmaceuticals (United States)","ror":"https://ror.org/023ka9926","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul J. Maddon","raw_affiliation_strings":["Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591","institution_ids":["https://openalex.org/I4210116119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017367178","display_name":"William C. Olson","orcid":"https://orcid.org/0000-0001-6254-0641","observed_orcids":["https://orcid.org/0000-0001-6254-0641"]},"institutions":[{"id":"https://openalex.org/I4210116119","display_name":"Progenics Pharmaceuticals (United States)","ror":"https://ror.org/023ka9926","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116119"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William C. Olson","raw_affiliation_strings":["Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591","institution_ids":["https://openalex.org/I4210116119"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017367178"],"corresponding_institution_ids":["https://openalex.org/I4210116119"],"apc_list":null,"apc_paid":null,"fwci":6.4957,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.97183594,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"50","issue":"10","first_page":"3289","last_page":"3296"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7134000062942505,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7134000062942505,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.21070000529289246,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.06019999831914902,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9449999928474426},{"id":"https://openalex.org/keywords/ccr5","display_name":"CCR5","score":0.9300000071525574},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7229999899864197},{"id":"https://openalex.org/keywords/maraviroc","display_name":"maraviroc","score":0.8349999785423279},{"id":"https://openalex.org/keywords/vicriviroc","display_name":"vicriviroc","score":0.996999979019165},{"id":"https://openalex.org/keywords/tak-779","display_name":"TAK-779","score":0.9980000257492065},{"id":"https://openalex.org/keywords/synergistic-antiviral-effect","display_name":"antiviral synergy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/combination-index","display_name":"combination index","score":0.6919999718666077},{"id":"https://openalex.org/keywords/ccl5","display_name":"RANTES","score":0.8100000023841858},{"id":"https://openalex.org/keywords/chemokine-receptor-binding","display_name":"chemokine receptor binding","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.6840000152587891},{"id":"https://openalex.org/keywords/hiv-1-entry","display_name":"HIV-1 entry","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C37044404","wikidata":"https://www.wikidata.org/wiki/Q5009692","display_name":"CCR5 receptor antagonist","level":5,"score":0.9268818497657776},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.8017781972885132},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7203223705291748},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.6382189393043518},{"id":"https://openalex.org/C45635710","wikidata":"https://www.wikidata.org/wiki/Q418404","display_name":"Chemokine receptor CCR5","level":5,"score":0.5889770984649658},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5367904901504517},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.5088744163513184},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4803841710090637},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4714528024196625},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4681459069252014},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.41712215542793274},{"id":"https://openalex.org/C58475186","wikidata":"https://www.wikidata.org/wiki/Q4118894","display_name":"Viral entry","level":4,"score":0.41696658730506897},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.41087862849235535},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4094684422016144},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.40114495158195496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3957135081291199},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.30647557973861694},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2823946177959442},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26993033289909363},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17373842000961304},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077592","descriptor_name":"Maraviroc","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008561","descriptor_name":"Membrane Fusion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019713","descriptor_name":"Receptors, CCR5","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065100","descriptor_name":"CCR5 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.00699-06","doi":"https://doi.org/10.1128/aac.00699-06","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00699-06","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1610098","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1610098","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:17005807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17005807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1610098","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1610098","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1595647639","display_name":"PA 14 CORECEPTOR-TARGETED IMMUNOTHERAPY OF HIV INFECTION","funder_award_id":"R43AI046871","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G1952406249","display_name":"HIV-1 Therapy with CCR5 mAB PRO 140-Overview","funder_award_id":"U19AI066329","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3671372310","display_name":null,"funder_award_id":"AI046871","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G8124027672","display_name":"Humanized PRO 140 for CCR5-Targeted Therapy of HIV","funder_award_id":"R44AI046871","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W565417519","https://openalex.org/W1906536207","https://openalex.org/W1971823321","https://openalex.org/W1974089699","https://openalex.org/W1981440980","https://openalex.org/W1981644527","https://openalex.org/W1991735339","https://openalex.org/W1996183144","https://openalex.org/W1999048558","https://openalex.org/W1999838828","https://openalex.org/W2004986240","https://openalex.org/W2005228785","https://openalex.org/W2005980845","https://openalex.org/W2022974362","https://openalex.org/W2025430406","https://openalex.org/W2026328614","https://openalex.org/W2031999671","https://openalex.org/W2039244520","https://openalex.org/W2044004371","https://openalex.org/W2050977299","https://openalex.org/W2051785641","https://openalex.org/W2053624248","https://openalex.org/W2058252938","https://openalex.org/W2059627765","https://openalex.org/W2063519379","https://openalex.org/W2066121768","https://openalex.org/W2069786625","https://openalex.org/W2076349085","https://openalex.org/W2077945404","https://openalex.org/W2092289188","https://openalex.org/W2105607249","https://openalex.org/W2107656195","https://openalex.org/W2110838631","https://openalex.org/W2129600342","https://openalex.org/W2135581465","https://openalex.org/W2138758139","https://openalex.org/W2140453379","https://openalex.org/W2140478082","https://openalex.org/W2143818994","https://openalex.org/W2146426059","https://openalex.org/W2150001263","https://openalex.org/W2150809120","https://openalex.org/W2155075889","https://openalex.org/W2155881222","https://openalex.org/W2160767768","https://openalex.org/W2164478346","https://openalex.org/W2170412417","https://openalex.org/W2171411599","https://openalex.org/W2318289184","https://openalex.org/W2415009490"],"related_works":["https://openalex.org/W1507640682","https://openalex.org/W2145684699","https://openalex.org/W2069786625","https://openalex.org/W2054587758","https://openalex.org/W2051785641","https://openalex.org/W2107656195","https://openalex.org/W2031379259","https://openalex.org/W2150620497","https://openalex.org/W2000389827","https://openalex.org/W2317157283"],"abstract_inverted_index":{"The":[0,201],"chemokine":[1,173],"receptor":[2,161],"CCR5":[3,26,46,49,88,95,114,145,151,188,213],"provides":[4],"a":[5,175,204],"portal":[6],"of":[7,53,134,144,160,198,209],"entry":[8],"for":[9,66,178,185,206,219],"human":[10,30],"immunodeficiency":[11],"virus":[12],"type":[13],"1":[14],"(HIV-1)":[15],"into":[16,129],"susceptible":[17],"CD4(+)":[18],"cells.":[19],"Both":[20],"monoclonal":[21],"antibody":[22],"(MAb)":[23],"and":[24,51,57,75,92,101,117,127,149,168,190,211],"small-molecule":[25,48,94,150,187,212],"inhibitors":[27,52,214],"have":[28],"entered":[29],"clinical":[31,207],"testing,":[32],"but":[33],"little":[34],"is":[35],"known":[36],"regarding":[37],"their":[38],"potential":[39],"interactions.":[40],"We":[41],"evaluated":[42],"the":[43,70,87,93,158,172],"interactions":[44],"between":[45,86],"MAbs,":[47],"antagonists,":[50],"HIV-1":[54,112,199,220],"gp120,":[55],"gp41,":[56],"reverse":[58],"transcriptase":[59],"in":[60,130,193,215],"vitro.":[61],"Inhibition":[62],"data":[63],"were":[64,183],"analyzed":[65],"cooperative":[67],"effects":[68,182],"using":[69],"combination":[71,194],"index":[72],"(CI)":[73],"method":[74],"stringent":[76],"statistical":[77],"criteria.":[78],"Potent,":[79],"statistically":[80],"significant":[81],"antiviral":[82],"synergy":[83,104,155],"was":[84,105],"observed":[85,106,184],"MAb":[89,148,210],"PRO":[90,166,191],"140":[91,167,192],"antagonists":[96,189],"maraviroc":[97,169],"(UK-427,857),":[98],"vicriviroc":[99],"(SCH-D),":[100],"TAK-779.":[102],"High-level":[103],"consistently":[107],"across":[108],"various":[109],"assay":[110],"systems,":[111],"envelopes,":[113],"target":[115],"cells,":[116],"inhibition":[118],"levels.":[119],"CI":[120],"values":[121],"ranged":[122],"from":[123],"0.18":[124],"to":[125,136],"0.64":[126],"translated":[128],"vitro":[131],"dose":[132],"reductions":[133],"up":[135],"14-fold.":[137],"Competition":[138],"binding":[139,146],"studies":[140],"revealed":[141],"nonreciprocal":[142],"patterns":[143],"by":[147],"inhibitors,":[152],"suggesting":[153],"that":[154],"occurs":[156],"at":[157],"level":[159],"binding.":[162],"In":[163],"addition,":[164],"both":[165,186],"synergized":[170],"with":[171,195],"RANTES,":[174],"natural":[176],"ligand":[177],"CCR5;":[179],"however,":[180],"additive":[181],"other":[196],"classes":[197],"inhibitors.":[200],"findings":[202],"provide":[203],"rationale":[205],"exploration":[208],"novel":[216],"dual-CCR5":[217],"regimens":[218],"therapy.":[221]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}